Louisville, KY—Potentia Pharmaceuticals Inc., a development stage biotech company with a Phase I product initially aimed at age-related macular degeneration, has raised $12 million led by HealthCare Ventures and MASA Life Science Ventures. (more…)

Charleston, SC and Manchester UK– Myconostica Ltd, a Manchester UK-based medical diagnostic company specializing in rapid and highly specific tests for life-threatening fungal infections, today announces that it has closed an $7.7 million (£3.9M) oversubscribed round of financing from a number of leading international private equity investors. The new funds will be used to launch the company’s first two products and establish new US headquarters in Charleston, SC. (more…)

Miami, FL- H.I.G. Ventures, the venture capital affiliate of H.I.G. Capital, announced today the addition of Michael Gutch, Ph.D. to its life sciences investment team.  Michael will work with H.I.G. Managing Directors Aaron Davidson and Bruce Robertson in all stages of the investment process, concentrating on biopharmaceuticals and medical device opportunities. (more…)